ATE471338T1 - Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen - Google Patents

Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen

Info

Publication number
ATE471338T1
ATE471338T1 AT06831859T AT06831859T ATE471338T1 AT E471338 T1 ATE471338 T1 AT E471338T1 AT 06831859 T AT06831859 T AT 06831859T AT 06831859 T AT06831859 T AT 06831859T AT E471338 T1 ATE471338 T1 AT E471338T1
Authority
AT
Austria
Prior art keywords
hynic
interleukin
site
inflammations
hydrazine
Prior art date
Application number
AT06831859T
Other languages
English (en)
Inventor
Huub Rennen
Otto Boerman
Original Assignee
Stichting Katholieke Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Katholieke Univ filed Critical Stichting Katholieke Univ
Application granted granted Critical
Publication of ATE471338T1 publication Critical patent/ATE471338T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT06831859T 2005-10-14 2006-10-13 Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen ATE471338T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05077365 2005-10-14
PCT/IB2006/003899 WO2007042946A2 (en) 2005-10-14 2006-10-13 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation

Publications (1)

Publication Number Publication Date
ATE471338T1 true ATE471338T1 (de) 2010-07-15

Family

ID=37943188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06831859T ATE471338T1 (de) 2005-10-14 2006-10-13 Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen

Country Status (13)

Country Link
US (1) US20080233084A1 (de)
EP (1) EP1934251B1 (de)
JP (1) JP2009511565A (de)
CN (1) CN101296941A (de)
AT (1) ATE471338T1 (de)
AU (1) AU2006300823A1 (de)
BR (1) BRPI0617195A2 (de)
CA (1) CA2625993A1 (de)
DE (1) DE602006014980D1 (de)
IL (1) IL190581A0 (de)
RU (1) RU2008114208A (de)
WO (1) WO2007042946A2 (de)
ZA (1) ZA200801921B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251364B1 (en) * 1999-03-29 2001-06-26 Dupont Pharmaceuticals Company Ternary ligand complexes useful as radiopharmaceuticals
WO2002082044A2 (en) * 2001-04-03 2002-10-17 The Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
EP1283216A1 (de) * 2001-08-10 2003-02-12 Mallinckrodt Inc. Alle somatostatinrezeptorsubtypen-bindende Somatostatinanaloge und deren Verwendung

Also Published As

Publication number Publication date
AU2006300823A1 (en) 2007-04-19
IL190581A0 (en) 2008-11-03
JP2009511565A (ja) 2009-03-19
WO2007042946A3 (en) 2007-10-04
BRPI0617195A2 (pt) 2011-07-19
EP1934251A2 (de) 2008-06-25
DE602006014980D1 (de) 2010-07-29
RU2008114208A (ru) 2009-11-20
CN101296941A (zh) 2008-10-29
EP1934251B1 (de) 2010-06-16
ZA200801921B (en) 2010-09-29
CA2625993A1 (en) 2007-04-19
WO2007042946A2 (en) 2007-04-19
US20080233084A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
DK1571970T3 (da) Diagnose og monitorering af sygdomme
CY2018013I1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BRPI0513959A (pt) anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
WO2008030973A3 (en) Methods and compositions for the detection of protein folding disorders
MA29836B1 (fr) Proteines de fusion avec l'albumine
MY148086A (en) Antibodies directed against amyloid-beta peptide and methods using same
PE20090711A1 (es) Region constante de anticuerpo mutante
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
RS54127B1 (en) ANTIBODIES NEUTRALIZERS OF THE HUMAN FACTOR OF STIMULATION OF THE COLONIA OF THE GRANULLocyte MACROPHAGUS
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
WO2009009727A3 (en) Ghrh analogs and therapeutic uses thereof
HRP20140888T1 (hr) Humana monoklonalna protutijela za humani il-4
DE602005020639D1 (de) Zusammensetzung aus milchsäure und lactoferrin
TW200617174A (en) Method of diagnosing lawsonia intracellularis
ECSP10010196A (es) Derivados de amidas del ácido 6,7-dihidro-5h-imidazo[1,2-a]imidazol-3-carboxílico
CY1110170T1 (el) Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
WO2008127680A3 (en) Diagnosis and treatment of diseases caused by misfolded proteins
WO2007074456A3 (en) Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids
WO2006079057A3 (en) Methods and compositions for specific inhibition of protein splicing by small molecules
ATE471338T1 (de) Durch ein oder mehrere standortspezifisch konjugierte hydrazin-nikotin-amid(hynic)-teile markiertes interleukin-8 und seine verwendung zur diagnostizierung von infektionen und entzündungen
JP2008537481A5 (de)
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
GB0611708D0 (en) Novel antibodies against prion protein and uses thereof
IL177698A0 (en) Fusion proeins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties